Premium
P4‐662: PHASE 1B OPEN‐LABEL, BIOMARKER‐DIRECTED STUDY OF THE BRAIN PENETRANT, SOLUBLE SELECTIVE INHIBITOR OF SOLUBLE TUMOR NECROSIS FACTOR XPRO1595 IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE
Author(s) -
Barnum Christopher,
Tansey Malu G.,
Tesi Raymond
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.09.028
Subject(s) - disease , medicine , tumor necrosis factor alpha , neuroinflammation , biomarker , oncology , bioinformatics , immunology , biology , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom